A Study of Seltorexant in Participants With Probable Alzheimer's Disease

NCT05307692 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Seltorexant
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC